Monday, June 30, 2025 6/30/2025

Addressing System-level Barriers to COPD Guideline Concordant Care

Award Number: R01HL161049
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 02/01/2022
PERIOD OF PERFORMANCE END DATE: 01/31/2025

Group Awards By:

View Award Description

Addressing System-level Barriers to COPD Guideline Concordant Care - Project Summary/Abstract This supplement aims to support Hewlett Pham for two years prior to medical school matriculation to help him build a strong foundation grounded in clinical research and achieve his career goals of attending medical school and becoming an independent researcher. This research fellowship will provide Hewlett with an opportunity to develop his cognitive skills to implement a care bundle with evidence-based care components, technical skills to analyze clinical data, interpret results, educate providers and patients; and additional research skills including implementation science and biostatistics. Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) have led to worse patient health outcomes and a heavy economic burden on hospital healthcare systems. Overall, the effectiveness of COPD discharge care bundles has been found to reduce hospital readmission rates; however, other health care outcomes results such as mortality rates and quality of life have been variable due to a lack of standardized bundle components and implementation. This emphasizes the need for high-quality studies to identify and implement the most evidence-based components of a COPD discharge care bundle to improve patient health outcomes. Hewlett’s research project fulfills this need and will investigate the impact of COPD discharge care bundles in a large healthcare system setting. Specific Aim 1 of the supplement will identify evidence-based components for an effective COPD discharge care bundle. Specific Aim 2 will develop a COPD discharge bundle with frontline providers and patients using PDSA cycles. Specific Aim 3 will pilot the developed COPD Discharge care bundle on hospital readmissions using an interrupted time series design. This research topic is within the scope of the parent grant, which focuses on improving the care delivery for individuals with COPD, specifically, it evaluates the benefit of a pulmonary rehabilitation program on improving COPD health outcomes. This supplement will have the added benefit of increasing awareness and referral rates to pulmonary rehabilitation by integrating this guideline recommendation into the COPD discharge care bundle.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $617,795 )
2025	2025	REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE	1855 FOLSOM ST STE 425	SAN FRANCISCO	CA	94103	SAN FRANCISCO	USA	Lung Diseases Research	001	4	4/23/2025	NON-COMPETING CONTINUATION	$0
2025	2025	REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE	1855 FOLSOM ST STE 425	SAN FRANCISCO	CA	94103	SAN FRANCISCO	USA	Lung Diseases Research	000	4	4/5/2025	NON-COMPETING CONTINUATION	$617,795
2025	2024	REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE	1855 FOLSOM ST STE 425	SAN FRANCISCO	CA	94103	SAN FRANCISCO	USA	Lung Diseases Research	002	3	6/4/2025	SUPPLEMENT FOR EXPANSION	$0
														Subtotal = $617,795

Issue Date FY: 2024 ( Subtotal = $733,084 )
2024	2024	REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE	1855 FOLSOM ST STE 425	SAN FRANCISCO	CA	94103	SAN FRANCISCO	USA	Lung Diseases Research	000	3	7/18/2024	NON-COMPETING CONTINUATION	$673,890
2024	2024	REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE	1855 FOLSOM ST STE 425	SAN FRANCISCO	CA	94103	SAN FRANCISCO	USA	Lung Diseases Research	001	3	9/5/2024	SUPPLEMENT FOR EXPANSION	$59,194
														Subtotal = $733,084

Issue Date FY: 2023 ( Subtotal = $688,345 )
2023	2023	REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE	1855 FOLSOM ST STE 425	SAN FRANCISCO	CA	94143	SAN FRANCISCO	USA	Lung Diseases Research	001	2	3/15/2023	NON-COMPETING CONTINUATION	$68,834
2023	2023	REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE	1855 FOLSOM ST STE 425	SAN FRANCISCO	CA	94143	SAN FRANCISCO	USA	Lung Diseases Research	000	2	1/19/2023	NON-COMPETING CONTINUATION	$619,511
														Subtotal = $688,345

Issue Date FY: 2022 ( Subtotal = $704,451 )
2022	2022	REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE	1855 FOLSOM ST STE 425	SAN FRANCISCO	CA	94143	SAN FRANCISCO	USA	Lung Diseases Research	000	1	1/28/2022	NEW	$704,451
														Subtotal = $704,451

Grand Total All Awards = $2,743,675

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Addressing System-level Barriers to COPD Guideline Concordant Care

Award Number: R01HL161049

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 02/01/2022

PERIOD OF PERFORMANCE END DATE: 01/31/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer